Shinva Medical Instrument Co.,Ltd.

SHSE:600587 Stock Report

Market Cap: CN¥10.7b

Shinva Medical InstrumentLtd Future Growth

Future criteria checks 2/6

Shinva Medical InstrumentLtd is forecast to grow earnings and revenue by 22.3% and 12% per annum respectively. EPS is expected to grow by 19.8% per annum. Return on equity is forecast to be 11.6% in 3 years.

Key information

22.3%

Earnings growth rate

19.8%

EPS growth rate

Medical Equipment earnings growth26.1%
Revenue growth rate12.0%
Future return on equity11.6%
Analyst coverage

Low

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Oct 01
Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Sep 16
Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Aug 08
Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18
Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07
Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22
Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28
Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Earnings and Revenue Growth Forecasts

SHSE:600587 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,4551,183N/A1,9812
12/31/202512,141976N/A1,5012
12/31/202410,963817N/A5562
9/30/202410,118692329706N/A
6/30/202410,125680425865N/A
3/31/202410,102669281800N/A
12/31/202310,0126544941,030N/A
9/30/20239,948659179730N/A
6/30/20239,919636321757N/A
3/31/20239,608569434757N/A
12/31/20229,282500140388N/A
9/30/20228,778539-20563N/A
6/30/20228,457550-37216N/A
3/31/20229,078538465720N/A
12/31/20219,4825561,1281,403N/A
9/30/20219,9744591,5711,750N/A
6/30/202110,5914351,6391,866N/A
3/31/20219,9383471,2211,429N/A
12/31/20209,1512349071,098N/A
9/30/20208,983272722823N/A
6/30/20208,616297602705N/A
3/31/20208,470333360527N/A
12/31/20198,767861415631N/A
9/30/20199,347671258922N/A
6/30/20199,814659328940N/A
3/31/201910,1355564181,111N/A
12/31/201810,28423-73653N/A
9/30/201810,144207346860N/A
6/30/201810,11638N/A741N/A
3/31/201810,05150N/A664N/A
12/31/20179,98366N/A959N/A
9/30/20179,551-100N/A554N/A
6/30/20179,09125N/A523N/A
3/31/20178,69636N/A523N/A
12/31/20168,36435N/A189N/A
9/30/20168,139223N/A210N/A
6/30/20167,895236N/A235N/A
3/31/20167,686244N/A-125N/A
12/31/20157,554281N/A110N/A
9/30/20157,256291N/A-110N/A
6/30/20157,000308N/A-209N/A
3/31/20156,749320N/A-76N/A
12/31/20146,283326N/A52N/A
9/30/20145,613303N/A-19N/A
6/30/20144,999280N/A-29N/A
3/31/20144,476265N/A5N/A
12/31/20134,194232N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600587's forecast earnings growth (22.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 600587's earnings (22.3% per year) are forecast to grow slower than the CN market (25.7% per year).

High Growth Earnings: 600587's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600587's revenue (12% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 600587's revenue (12% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600587's Return on Equity is forecast to be low in 3 years time (11.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 23:05
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shinva Medical Instrument Co.,Ltd. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Huimin WuChina International Capital Corporation Limited
Andy LiuChina Stock Investment Research Co. Ltd. (GZ500..com)